As you may have heard, the FDA has granted limited prescriptive authority to pharmacists for COVID-19 antiviral, Paxlovid. Test-to-Treat is here.
What does this really mean for pharmacy? And what’s next to operationalize Test-to-Treat within the pharmacy environment?
Hear David Pope, PharmD, CDE, Chief of Pharmacy and Shelley Hansell, EVP Client Relations & RCM Product Management in a townhall-style webinar, to discuss all of the crucial nuances involved in pharmacy’s Test-to- Treat model – including medical billing strategies.